FDA Brief

Warning letters Drugs

FDA warning letter to

Aja Health and Wellness Inc.

MediumIssued May 18Posted May 26Center for Drug Evaluation and Research (CDER)

FDA warns Aja Health and Wellness that its Aja Migraine Relief nasal spray is an unapproved, misbranded OTC drug.

What happened

FDA reviewed the company’s website, https://easemyheadache.com/, in February 2026. FDA found Aja Migraine Relief, a nasal spray labeled for migraine relief, marketed as an unapproved new drug (sold without FDA approval and not generally recognized as safe and effective) and misbranded (unlawfully labeled or marketed). FDA said it does not meet the OTC monograph (FDA’s rule for nonprescription internal pain products) because it is meant for use inside the nostrils, makes migraine and inflammation claims the rule does not allow, and uses BioFlora™ blend, an ingredient the rule does not permit.

What FDA found

  1. Aja Migraine Relief is an unapproved new drug because no FDA-approved application is in effect for it and it is not generally recognized as safe and effective.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. The product is misbranded because it is a nonprescription drug subject to section 505G but does not comply with that section and has no approved application.

    FD&C Act section 502(ee), 21 U.S.C. 352(ee)
  3. The product does not fit OTC monograph M013 because that rule covers internal pain products suitable for oral administration, not a product intended for use inside the nostrils.

    M013.1
  4. Its labeling claims migraine relief and quick easing of inflammation, uses not permitted for OTC internal analgesic products under the monograph.

    M013.50(b)
  5. It is formulated with BioFlora blend, which FDA treats as an active ingredient not permitted for OTC internal analgesics under the monograph.

    M013.10

What FDA wants

Send a written response to FDAAdvisory@fda.hhs.gov within 15 business days of receipt, with the specific steps taken to correct the violations, steps to prevent recurrence, related documentation, and reference number 729644 in the subject line.

Who should pay attention

  • OTC drug brands selling migraine or pain products online
  • companies relying on OTC monograph M013 for internal analgesics
  • retailers and marketplaces carrying Aja Migraine Relief

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk